Associate Professor, Internal Medicine, Washington University School of Medicine
Oncology
Dr. Benjamin R. Tan Jr., MD
|
|
Give Review
Benjamin R. Tan Jr. practices Oncology. He studied medicine at University of the Philippines College of Medicine. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Benjamin R. Tan Jr., MD is a published MD. He has 32 publications published. The most current publication "Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI..." Benjamin accepts Medicare payments and is registered with Medicare.gov.
Publications
- Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI...
- A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in a resected pancreaticoBiliary carcinoma.
- Histological features and severity of oxaliplatin-induced Liver injury and clinical associations.
- A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies.
- Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer.
- Complete response and prolonged Disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6.
- A multidisciplinary approach to the diagnosis and treatment of gastrointestinal stromal tumor.
- Geriatric assessment is associated with completion of chemotherapy, toxicity and survival in older adults with Cancer.
- Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with Rectal adenocarcinoma.
- A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
- Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic Cancer.
- Radiotherapy for epidermoid Carcinoma of the anus: thirty years' experience.
- Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenoCarcinoma: a single-institution phase II study.
- Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal Cancer patients treated with cetuximab.
- Expression of epidermal growth factor receptor in squamous cell carcinomas of the Anal cAnal is independent of gene amplification.
- Pharmacogenetic influences on treatment response and toxicity in colorectal Cancer.
- Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.
- Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
- Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.
- Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction Cancers.
- Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.
- Treatment advances in non-Hodgkin''s Lymphoma.
- Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.
- Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal Cancer.
- Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.
- Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.
- Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies.
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
- Gemcitabine with carboplatin for advanced biliary tract Cancers: a phase II single institution study.
- Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.
- A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB)...
Schools
University of The Philippines System Institute of Health Science
Sinai Hospital Baltimore
Wash University Barnes Jewish Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University -
Sinai Hospital of Baltimore -
University of the Philippines College of Medicine
Hospital
-
Barnes-Jewish Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Peter D. Weiss, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Westervelt, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Meagan A. Jacoby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine N. Weilbaecher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda Cashen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Lukas D. Wartman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John F. Dipersio, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bruce J. Roth, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Timothy A. Graubert, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|